Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow)
← catalyst calendarNCT02861183 · readout ≤ 254 d
Sponsored by Anika Therapeutics, Inc. (industry) · ANIK — their whole pipeline →.
Phase
Not applicable
Status
Withdrawn
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
0actual
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
Project was placed on hold indefinitely as the project resources were unavailable for this to move forward.
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Sep 2025 | estimated | When the study began enrolling |
| Primary completion | Apr 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Oct 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2016-08-10 | estimated | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2022-11-30 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Epicondylitis
- Tennis Elbow
- Epicondylosis
Interventions
- Device: OVT (Sodium Hyaluronate)
- Device: Saline
Primary outcome
what the primary-completion date above is the date OFChange from baseline in elbow pain after grip as measured by a 100 mm Visual Analog Scale (VAS) at 12 weeks comparing the OVT group to the saline control group
measured 12 weeks post injection
Permalink · ANIK's whole pipeline · Catalyst calendar · Every registered study · What changed